49 related articles for article (PubMed ID: 17556636)
21. Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation.
Olvera-Vargas H; Leroy S; Rivard M; Oturan N; Oturan M; Buisson D
Environ Sci Pollut Res Int; 2016 Nov; 23(22):22691-22700. PubMed ID: 27557972
[TBL] [Abstract][Full Text] [Related]
22. Humanized thymidine kinase-NOG mice can be used to identify drugs that cause animal-specific hepatotoxicity: a case study with furosemide.
Xu D; Michie SA; Zheng M; Takeda S; Wu M; Peltz G
J Pharmacol Exp Ther; 2015 Jul; 354(1):73-8. PubMed ID: 25962391
[TBL] [Abstract][Full Text] [Related]
23. Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.
Burkhart KK; Abernethy D; Jackson D
J Med Toxicol; 2015 Jun; 11(2):265-73. PubMed ID: 25876064
[TBL] [Abstract][Full Text] [Related]
24. The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury.
McGill MR; Du K; Xie Y; Bajt ML; Ding WX; Jaeschke H
Xenobiotica; 2015 May; 45(5):442-9. PubMed ID: 25423287
[TBL] [Abstract][Full Text] [Related]
25. Reactive metabolites in the biotransformation of molecules containing a furan ring.
Peterson LA
Chem Res Toxicol; 2013 Jan; 26(1):6-25. PubMed ID: 23061605
[TBL] [Abstract][Full Text] [Related]
26. Potent agonists of the protease activated receptor 2 (PAR2).
Boitano S; Flynn AN; Schulz SM; Hoffman J; Price TJ; Vagner J
J Med Chem; 2011 Mar; 54(5):1308-13. PubMed ID: 21294569
[TBL] [Abstract][Full Text] [Related]
27. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.
Antoine DJ; Williams DP; Kipar A; Laverty H; Park BK
Mol Med; 2010; 16(11-12):479-90. PubMed ID: 20811657
[TBL] [Abstract][Full Text] [Related]
28. Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery.
Shu YZ; Johnson BM; Yang TJ
AAPS J; 2008; 10(1):178-92. PubMed ID: 18446518
[TBL] [Abstract][Full Text] [Related]
29. Haloacetonitriles: metabolism and toxicity.
Lipscomb JC; El-Demerdash E; Ahmed AE
Rev Environ Contam Toxicol; 2009; 198():169-200. PubMed ID: 19253036
[TBL] [Abstract][Full Text] [Related]
30. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Cruzan G; Bus J; Banton M; Gingell R; Carlson G
Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
[TBL] [Abstract][Full Text] [Related]
31. The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore.
Williams DP; Antoine DJ; Butler PJ; Jones R; Randle L; Payne A; Howard M; Gardner I; Blagg J; Park BK
J Pharmacol Exp Ther; 2007 Sep; 322(3):1208-20. PubMed ID: 17556636
[TBL] [Abstract][Full Text] [Related]
32. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
34. Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine.
Jewell H; Maggs JL; Harrison AC; O'Neill PM; Ruscoe JE; Park BK
Xenobiotica; 1995 Feb; 25(2):199-217. PubMed ID: 7618347
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
36. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
